Buy Sun Pharma Advanced Research, target price Rs 145: IIFL
IIFL recommended to keep a stop loss at Rs 120.

Sun Pharma Advanced Research, incorporated in the year 2006, is a mid cap company (having a market cap of Rs 3,394.83 crore) operating in the pharmaceuticals sector.
Sun Pharma Advanced Research key products/revenue segments include sale of services which contributed Rs 182.87 crore to sales value (100.00 per cent of total sales) for the year ending 31 March, 2019.
For the quarter ended 30-06-2019, the company has reported standalone sales of Rs 17.32 crore, down 79.58 per cent from last quarter sales of Rs 84.83 crore and up 3.03 per cent from last year same quarter sales of Rs 16.81 crore. The company has reported a net profit after tax of Rs 94.19 crore in latest quarter. The company’s top management includes Ferzaan Engineer, T Rajamannar, Dilip S Shanghvi, Mark Simon, Sudhir V Valia and Bhavna Doshi. The company has S R B C & Co. LLP as its auditor. As on 30-06-2019, the company has a total of 262,047,506 shares outstanding.
Download ET Markets APP